Patent · US Active

Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof

US9192645B2 · kind B2 · utility

0Cited by

24References

15Claims

0Family size

Assignee

University of South Florida · US

Inventors

Jin Q. Cheng · Tampa, US
Said M. Sebti · Tampa, US

Key dates

Filing date	Jul 1, 2014
Grant date	Nov 24, 2015
Priority date	—
Expiry date	Jul 1, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This application relates to combination therapies including triciribine and related compounds and bortezomib and derivatives thereof analogs and compositions with reduced toxicity for the treatment and prevention of tumors, cancer, and other disorders associated with abnormal cell proliferation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.